Article Information
History
- September 4, 2023.
Article Versions
- Version 1 (September 1, 2023 - 12:12).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Monique Okeke1,
- Peter M. Eze1,2,*,
- Adaeze E. Chukwudebelu1,
- Chidiebere J. Nwankwo1,
- Nchekwube K. Eze3,
- Uchenna U. Okafor3,
- Isaiah C. Abonyi1,
- Eric E. Okereke1,
- Kalu O. Obasi1,
- Okorie A. Ede1,
- Chika P. Ejikeugwu4,5,
- Cajetan I. Ilo6 and
- Jerome O. Okafor7
- 1Department of Environmental Health Science, Nnamdi Azikiwe University, Nigeria
- 2School of Biological Science, Queen’s University Belfast, United Kingdom
- 3Department of Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University, Nigeria
- 4Department of Pharmaceutical Microbiology and Biotechnology, Enugu State University of Science and Technology, Nigeria
- 5Helmholtz-Zentrum für Umweltforschung (UFZ), Leipzig, Germany
- 6Department of Human Kinetics and Health Education, Ebonyi State University, Nigeria
- 7Department of Human Kinetics and Health Education, Nnamdi Azikiwe University, Nigeria
- ↵*Correspondence: p.eze{at}qub.ac.uk
Posted September 04, 2023.
Tuberculosis and HIV/AIDS Co-infection in Patients Attending Directly Observed Treatment Short-Course (DOTS) Centers in Anambra State, Nigeria
